Physician profile
Julia Bishop
NPI 1386474401
$553.89
in general payments reported to CMS, 2019-2025
9 companies · $554 in 2025
The $554 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $554.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $534 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $533.67 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $106.98 | 2025 | Verquvo, Capvaxive |
| Boston Scientific Corporation | $97.61 | 2025 | Cds - Mct/Cem Monitoring |
| Bayer Healthcare Pharmaceuticals INC. | $92.86 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $71.64 | 2025 | Camzyos, Eliquis |
| Novo Nordisk INC | $52.81 | 2025 | Wegovy |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $49.73 | 2025 | Lifevest |
| Amgen INC. | $34.38 | 2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.55 | 2025 | Jardiance |
| Pfizer INC. | $19.33 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Bishop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.